SC: CIRP Need Not Be Set Aside Solely for Fraudulent Filing of Section 9 Plea || Supreme Court: Compromise Decree Passed Without Impleading Necessary Party is Void || SC: Cheque Dishonour Notice Valid if Sent to Drawer’s Address and Received by Family || J&K&L HC: Minority During Attestation Cannot Justify Decades-Long Delay in Challenging Mutation || Bombay HC: WhatsApp Circulation of Objectionable Photos Can Attract SC/ST Act || J&K&L HC: Cardiac Arrest From Stress of Long-Distance Driving is Compensable || Delhi HC: Accused Cannot Delay Trial and Then Rely on Delay to Seek Bail || Calcutta HC: Insurer Must Compensate Child’s Accidental Death Despite Driver’s Fake Licence || Bombay HC Tells X to Take Down Defamatory Post Targeting Serum Institute, CEO Adar Poonawalla || Delhi High Court Restores Arbitral Award in DMRC’s Favour Passed by Employee-Arbitrator

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :